On August 27, 2025 Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, reported that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, and Philippe Sauvage, Chief Financial Officer of Nuvation Bio, will participate in three upcoming investor conferences, including fireside chats at two conferences (Press release, Nuvation Bio, AUG 27, 2025, View Source [SID1234655535]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Global Healthcare Conference 2025 on Thursday, September 4, 2025, at 2:10 p.m. ET in New York, NY
H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9, 2025, at 11:30 a.m. ET in New York, NY
The management team will participate in one-on-one meetings at the Citi 2025 BioPharma Back to School Conference on Wednesday, September 3, 2025, in Boston, MA.

Live webcasts of each fireside chat will be available on the Investor Relations section of the Nuvation Bio website. An archived recording will be available for 90 days following each event.